Skip to main contentAI and Advanced
/
ALBERTDAVD · NSEBSE SENSEX74,240.28-0.13%BSE |
NIFTY 5023,215.85-0.01%NSE |
NIFTY BANK56,063.8-0.41%NSE |
NIFTY IT28,889.4-0.68%NSE |
NIFTY AUTO27,087.05+0.72%NSE |
NIFTY FMCG45,636.6+0.17%NSE |
NIFTY PHARMA26,324.75+0.68%NSE |
NIFTY 50022,579.3+0.21%NSE |
AL
NSE · Equity shares · Biotechnology & Drugs-156.00 · -1.55%
Albert David ALBERTDAVD
NSE:INR 700.25
BSE:INR 843
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for ALBERTDAVD
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 856.25
Day rangeINR 835 — INR 870.05
52-week rangeINR 579.9 — INR 938.75
Volume4,783
Market cap394.62
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)333.6
Net Income (INR Cr)-1.49
Rev Growth (5 Year %)6.16
Book Value685.02
EPS-2.66
Price/BV1.02Computed
Research path: Interpret Albert David's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
ALBERTDAVDAlbert David1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 519.13 | 511.42 | 497.99 |
| Accumulated Depreciation Total | -156.5 | -149.8 | -145.23 |
| Other Liabilities Total | 6.74 | 7.1 | 12.08 |
| Accrued Expenses | 30.51 | 35.99 | 39.86 |
| Common Stock Total | 5.71 | 5.71 | 5.71 |
| Other Equity Total | 5.68 | 5.49 | 6.32 |
| Other Current Assets Total | 2.38 | 2.6 | 2.55 |
| Prepaid Expenses | 0.5 | 0.68 | 0.28 |
| Total Assets | 519.13 | 511.42 | 497.99 |
| Current Portof LT Debt/Capital Leases | 0.75 | 0.94 | 0.62 |
| Additional Paid-In Capital | 3.15 | 3.15 | 3.15 |
| Cash | 0.3 | 0.42 | 5.44 |
| Total Equity | 391.54 | 392.48 | 382.98 |
| Long Term Investments | 19.8 | 54.75 | 32.84 |
| Retained Earnings(Accumulated Deficit) | 377 | 378.13 | 367.81 |
| Total Common Shares Outstanding | 0.57 | 0.57 | 0.57 |
| Property/Plant/Equipment Total-Gross | 276.33 | 249.24 | 233.5 |
| Tangible Book Valueper Share Common Eq | 685.02 | 685.5 | 667.81 |
| Total Liabilities | 127.6 | 118.93 | 115.01 |
| Total Debt | 29.58 | 12.32 | 3.32 |
| Short Term Investments | 257.28 | 243.24 | 279.79 |
| Cashand Short Term Investments | 257.58 | 243.66 | 285.23 |
| Total Receivables Net | 53.23 | 41.66 | 37.58 |
| Notes Payable/Short Term Debt | 28.48 | 10.05 | 2.1 |
| Deferred Income Tax | 5.07 | 6.32 | 3.28 |
| Accounts Receivable-Trade Net | 35.76 | 29.52 | 31.11 |
| Property/Plant/Equipment Total-Net | 119.83 | 99.44 | 88.28 |
| Total Current Liabilities | 115.43 | 104.18 | 99.05 |
| Total Inventory | 60.71 | 65.45 | 46 |
| Accounts Payable | 32.52 | 37.56 | 33.95 |
| Other Currentliabilities Total | 23.18 | 19.65 | 22.52 |
| Total Long Term Debt | 0.35 | 1.33 | 0.6 |
| Intangibles Net | 0.58 | 1.26 | 1.85 |
| Other Long Term Assets Total | 3.03 | 1.51 | 3 |
| Note Receivable-Long Term | 1.48 | 0.4 | 0.39 |
| Total Current Assets | 374.4 | 354.05 | 371.63 |
| Capital Lease Obligations | 0.35 | 1.33 | 0.6 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %78.8
Margins
Operating Margin 12m-1.29
Operating Margin 5y Avg6.15
Net Profit Margin 12m-0.45
Net Profit Margin 5y9.58
Yield
Dividend Yield %0.72
Valuation
Price to Sale Ratio1.18
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk42.13
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,937.7 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,370 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,972.85 | 1.68 L | 72.73 | — |
| Cipla | INR 1,411.25 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,122 | 1.12 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 62.24%
- FII
- 0.57%
- MF
- 0.01%
- Other
- 37.18%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Albert David operations head resigns from Ghaziabad Plant - scanx.tradeMarket news · 30 May 2026, 4:44 pm
Albert David operations head resigns from Ghaziabad Plant scanx.trade
Albert David Ltd Falls to 52-Week Low Amid Continued Downtrend - Markets MojoMarket news · 25 May 2026, 1:46 am
Albert David Ltd Falls to 52-Week Low Amid Continued Downtrend Markets Mojo
Albert David Ltd is Rated Sell - Markets MojoMarket news · 15 May 2026, 1:56 pm
Albert David Ltd is Rated Sell Markets Mojo
Albert David FY26 Net Loss ₹149.47 Lakh; Dividend ₹5 - scanx.tradeMarket news · 14 May 2026, 12:30 pm
Albert David FY26 Net Loss ₹149.47 Lakh; Dividend ₹5 scanx.trade
Albert David Q4 FY26: Sharp Loss Derails Recovery Momentum - Markets MojoMarket news · 13 May 2026, 12:07 pm
Albert David Q4 FY26: Sharp Loss Derails Recovery Momentum Markets Mojo
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.comMarket news · 12 May 2026, 12:30 pm
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y Moneycontrol.com
Corporate actions
Events
- annual General MeetingAGM
- dividendRs.5.0000 per share(50%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingPOM
- annual General MeetingPOM
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Albert David
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- ALBERTDAVD
- BSE Code
- 524075
Questions
Stock FAQ
What is the symbol and ISIN of Albert David?
Albert David has the symbol ALBERTDAVD and ISIN - INE155C01010.
What is the current price of Albert David?
Albert David is currently trading at INR 700.25.
What are the year high and year low of Albert David?
Albert David has a year high of INR 938.75 and a year low of INR 579.90.
What is the market capitalization of Albert David?
Albert David has a market capitalization of INR 394.62 crore.
What is the P/E ratio of Albert David?
Albert David has a P/E ratio of NA.
What is the dividend yield of Albert David?
Albert David has a dividend yield of 0.72%.
How is the financial performance of Albert David based on revenue, net income, and EPS?
Albert David has revenue of INR 333.60 crore, net income of INR -1.49 crore, and EPS of INR -2.62.
What is the book value of Albert David?
Albert David has a book value of INR 685.02.
What is the debt-to-equity ratio of Albert David?
Albert David has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Albert David?
Albert David has a price-to-book ratio of 1.02 and a price-to-sales ratio of 1.18.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.